All In Biotech

Free tool

FAERS Monitor: Effient

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022307 or its brand name (Effient, Prasugrel Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

10,151

Serious

7,609

75% of reports

Hospitalization

3,996

Death reported

862

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • myocardial infarction510
  • gastrointestinal haemorrhage472
  • chest pain460
  • haemorrhage454
  • dyspnoea436
  • contusion425
  • fatigue333
  • off label use324
  • nausea308
  • dizziness302
  • thrombosis in device284
  • epistaxis254
  • headache251
  • asthenia228
  • diarrhoea224

Reports by year received

View as table
YearReports
20081
200956
2010598
2011786
2012827
2013502
2014545
20152,703
2016817
2017667
2018503
2019414
2020259
2021216
2022379
2023321
2024167
2025209
2026181

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,008 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
thrombosis in deviceSignal284196.4174.250,274
gastrointestinal haemorrhageSignal47211.810.84,629
contusionSignal4259.28.43,091
haemorrhageSignal4549.08.33,238
epistaxisSignal2547.16.21,315
myocardial infarctionSignal5106.15.62,167
chest painSignal4605.24.71,547
dyspnoea4361.61.599
asthenia2281.31.112
dizziness3021.31.116
fatigue3330.90.85
headache2510.80.79
nausea3080.80.715
off label use3240.80.724
diarrhoea2240.70.625

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.